Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64
Published January 5, 2022 · Recall initiated: November 30, 2021
Summary
FDA records drug Class II recall D-0296-2022, published January 5, 2022 and initiated November 30, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Ongoing; Reported quantity: 7,176 bottles; Lot: Lot #: 15594, Exp Date 05/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: Minimally superpotent
What to do
Voluntary: Firm initiated · Letter
Get an email if LIDOCAINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- Teligent Pharma, Inc.
- Distributor
- Distributed to a wholesaler in CO who further distributed Nationwide in the USA
- Lot
- Lot #: 15594, Exp Date 05/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by EnovachemJuly 8, 2026
- FDALidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices,June 10, 2026
- FDALidocaine HCl injection, USP, 1% 50mg/5mL (10 mg/mL), 5 mL Single Dose Vials, Rx only, Manufactured by: HuonsApril 22, 2026
- FDALidocaine HCl Injection, USP, 2%, 100 mg/5mL (20 mg/mL), 5 mL Single-Dose Vials, Rx only, Manufactured by:April 22, 2026
- FDALidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only,January 5, 2022
- FDABetamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, Teligent Pharma Inc.,January 5, 2022
Questions about this recall
Was Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64 recalled?
Yes. FDA published recall D-0296-2022 on January 5, 2022. Reported hazard: Superpotent Drug: Minimally superpotent
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LIDOCAINE HYDROCHLORIDE.